One can see that patients were significantly split by OPN expression regarding both overall (P=0.034) and disease-free (P=0.011) survival; in fact, stage I NSCLC patients with high OPN expression had shorter overall and disease-free survival than those with low OPN expression. This evidence concerns the gene SPP1 and non-small cell lung carcinoma.